Delivery Order SPE2DR25D1202-SPE2DR26F72QM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $7,736.36. This is a firm fixed price delivery order with an ultimate completion date of October 31, 2025, and represents a non-competitive set-aside contract. The order will be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a contract value of $39,828.37. This is a firm fixed-price delivery order with an ultimate completion date of November 19, 2025. The contract was competitively awarded with no set-aside designation, and AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. As a child order, this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Jardiance 10 mg tablets in quantities of 90 units. This competitively awarded contract, valued at $34,528.08, represents a firm fixed-price delivery order with performance completion scheduled for August 28, 2025. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, and carries no set-aside designation. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $18,079.54 to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Jardiance 10 mg tablets in a 90-count quantity. The contract, which is not set-aside, carries a firm fixed price structure with an ultimate completion date of December 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $14,265.11 on November 14, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of November 17, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under the company's...
- The Defense Logistics Agency awarded a $34,327.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on December 5, 2025, with an ultimate completion date of December 8, 2025. This is an unset-aside, competitively awarded contract performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Jardiance 10 mg tablets (90-count) under a firm fixed-price contract valued at $21,295.85. This non-competitive, competitively awarded delivery order is scheduled for completion by August 21, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a ceiling value of $55,533.83. This firm fixed-price delivery order, which is expected to be completed by November 26, 2025, represents a non-competitive set-aside procurement supporting federal pharmaceutical supply needs. The contract is being performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a ceiling value of $13,245.31. This firm fixed-price delivery order, with an ultimate completion date of December 2, 2025, represents a competitively awarded, non-set-aside contract. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Jardiance 10 mg tablets (90-count units) under a firm fixed-price contract valued at $15,302.10. This is a non-set-aside award, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F72QMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Jardiance 10 mg tablets (90-count) under a firm fixed-price contract valued at $4,737.30, with completion scheduled for December 1, 2025. This non-competitive delivery order represents a pharmaceutical procurement supporting federal medical supply needs, with place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for the Defense Logistics Agency's Medical Supply Chain, fulfilling a broad portfolio of pharmaceutical products and medical supplies for military and veteran healthcare systems. The company's federal contracting history demonstrates consistent competitively awarded delivery orders with firm fixed pricing across diverse therapeutic domains, including diabetes medications, neurological treatments, and specialty pharmaceuticals. This Jardiance order reflects the company's ongoing role supporting the Defense Health Agency and other federal healthcare entities through flexible contract vehicles designed to ensure reliable pharmaceutical supply to military medical facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 11/27/25 |